JPS63317092A - Production of coenzyme q10 - Google Patents
Production of coenzyme q10Info
- Publication number
- JPS63317092A JPS63317092A JP62151059A JP15105987A JPS63317092A JP S63317092 A JPS63317092 A JP S63317092A JP 62151059 A JP62151059 A JP 62151059A JP 15105987 A JP15105987 A JP 15105987A JP S63317092 A JPS63317092 A JP S63317092A
- Authority
- JP
- Japan
- Prior art keywords
- coenzyme
- methanol
- culture
- medium
- cell
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000004519 manufacturing process Methods 0.000 title claims description 10
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 title abstract description 26
- 241000894006 Bacteria Species 0.000 claims abstract description 31
- 230000001580 bacterial effect Effects 0.000 claims description 26
- 239000005515 coenzyme Substances 0.000 claims description 6
- 238000012258 culturing Methods 0.000 claims description 6
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 abstract description 87
- 235000017471 coenzyme Q10 Nutrition 0.000 abstract description 24
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 abstract description 19
- 229940110767 coenzyme Q10 Drugs 0.000 abstract description 18
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 abstract description 8
- 239000000284 extract Substances 0.000 abstract description 8
- 239000001963 growth medium Substances 0.000 abstract description 6
- 239000001888 Peptone Substances 0.000 abstract description 5
- 108010080698 Peptones Proteins 0.000 abstract description 5
- 235000019319 peptone Nutrition 0.000 abstract description 5
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 abstract description 4
- 239000001301 oxygen Substances 0.000 abstract description 4
- 229910052760 oxygen Inorganic materials 0.000 abstract description 4
- 239000002689 soil Substances 0.000 abstract description 4
- 229910002651 NO3 Inorganic materials 0.000 abstract description 3
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 abstract description 3
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 2
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 abstract description 2
- 239000003674 animal food additive Substances 0.000 abstract description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 2
- 239000003795 chemical substances by application Substances 0.000 abstract description 2
- 239000008103 glucose Substances 0.000 abstract description 2
- 230000001766 physiological effect Effects 0.000 abstract description 2
- 239000000741 silica gel Substances 0.000 abstract description 2
- 229910002027 silica gel Inorganic materials 0.000 abstract description 2
- 230000000721 bacterilogical effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 230000001747 exhibiting effect Effects 0.000 abstract 1
- 230000001902 propagating effect Effects 0.000 abstract 1
- 230000000384 rearing effect Effects 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 31
- 239000000243 solution Substances 0.000 description 19
- 229920001817 Agar Polymers 0.000 description 17
- 239000008272 agar Substances 0.000 description 16
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 11
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 11
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 10
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 10
- 229910052799 carbon Inorganic materials 0.000 description 10
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 8
- 244000005700 microbiome Species 0.000 description 7
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 6
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 6
- 239000007788 liquid Substances 0.000 description 6
- 229910052757 nitrogen Inorganic materials 0.000 description 6
- 238000000926 separation method Methods 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000000034 method Methods 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 4
- 238000005273 aeration Methods 0.000 description 4
- 229910021529 ammonia Inorganic materials 0.000 description 4
- 229960002685 biotin Drugs 0.000 description 4
- 235000020958 biotin Nutrition 0.000 description 4
- 239000011616 biotin Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- 150000003863 ammonium salts Chemical class 0.000 description 3
- 239000007864 aqueous solution Substances 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000007789 gas Substances 0.000 description 3
- 235000013372 meat Nutrition 0.000 description 3
- 239000000203 mixture Substances 0.000 description 3
- 238000000746 purification Methods 0.000 description 3
- 239000002994 raw material Substances 0.000 description 3
- 235000017550 sodium carbonate Nutrition 0.000 description 3
- 229910000029 sodium carbonate Inorganic materials 0.000 description 3
- AZQWKYJCGOJGHM-UHFFFAOYSA-N 1,4-benzoquinone Chemical compound O=C1C=CC(=O)C=C1 AZQWKYJCGOJGHM-UHFFFAOYSA-N 0.000 description 2
- SRBFZHDQGSBBOR-IOVATXLUSA-N D-xylopyranose Chemical compound O[C@@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-IOVATXLUSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 description 2
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 2
- 241001057811 Paracoccus <mealybug> Species 0.000 description 2
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 2
- 244000052616 bacterial pathogen Species 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 239000004202 carbamide Substances 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000008273 gelatin Substances 0.000 description 2
- 229920000159 gelatin Polymers 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 150000002823 nitrates Chemical class 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- WQGWDDDVZFFDIG-UHFFFAOYSA-N pyrogallol Chemical compound OC1=CC=CC(O)=C1O WQGWDDDVZFFDIG-UHFFFAOYSA-N 0.000 description 2
- 238000007127 saponification reaction Methods 0.000 description 2
- 239000011780 sodium chloride Substances 0.000 description 2
- 235000011121 sodium hydroxide Nutrition 0.000 description 2
- 230000001954 sterilising effect Effects 0.000 description 2
- 238000003756 stirring Methods 0.000 description 2
- KDYFGRWQOYBRFD-UHFFFAOYSA-N succinic acid Chemical compound OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 2
- 238000012360 testing method Methods 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- NWONKYPBYAMBJT-UHFFFAOYSA-L zinc sulfate Chemical compound [Zn+2].[O-]S([O-])(=O)=O NWONKYPBYAMBJT-UHFFFAOYSA-L 0.000 description 2
- 229910000368 zinc sulfate Inorganic materials 0.000 description 2
- 239000011686 zinc sulphate Substances 0.000 description 2
- 235000009529 zinc sulphate Nutrition 0.000 description 2
- NOIRDLRUNWIUMX-UHFFFAOYSA-N 2-amino-3,7-dihydropurin-6-one;6-amino-1h-pyrimidin-2-one Chemical compound NC=1C=CNC(=O)N=1.O=C1NC(N)=NC2=C1NC=N2 NOIRDLRUNWIUMX-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 208000032467 Aplastic anaemia Diseases 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- 102000016938 Catalase Human genes 0.000 description 1
- 108010053835 Catalase Proteins 0.000 description 1
- 241001478240 Coccus Species 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- 108091006149 Electron carriers Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- 206010014561 Emphysema Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 241000283986 Lepus Species 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-M Nitrite anion Chemical compound [O-]N=O IOVCWXUNBOPUCH-UHFFFAOYSA-M 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000008865 Paraburkholderia denitrificans Species 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 108010046334 Urease Proteins 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 238000004847 absorption spectroscopy Methods 0.000 description 1
- 238000013019 agitation Methods 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 239000003513 alkali Substances 0.000 description 1
- 208000004631 alopecia areata Diseases 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- 150000001639 boron compounds Chemical class 0.000 description 1
- 235000014121 butter Nutrition 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 239000005018 casein Substances 0.000 description 1
- BECPQYXYKAMYBN-UHFFFAOYSA-N casein, tech. Chemical compound NCCCCC(C(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(CC(C)C)N=C(O)C(CCC(O)=O)N=C(O)C(CC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(C(C)O)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=N)N=C(O)C(CCC(O)=O)N=C(O)C(CCC(O)=O)N=C(O)C(COP(O)(O)=O)N=C(O)C(CCC(O)=N)N=C(O)C(N)CC1=CC=CC=C1 BECPQYXYKAMYBN-UHFFFAOYSA-N 0.000 description 1
- 235000021240 caseins Nutrition 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 150000001868 cobalt Chemical class 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000011109 contamination Methods 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- ARUVKPQLZAKDPS-UHFFFAOYSA-L copper(II) sulfate Chemical compound [Cu+2].[O-][S+2]([O-])([O-])[O-] ARUVKPQLZAKDPS-UHFFFAOYSA-L 0.000 description 1
- 229910000366 copper(II) sulfate Inorganic materials 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 238000012136 culture method Methods 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 238000000921 elemental analysis Methods 0.000 description 1
- 238000002474 experimental method Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 239000008394 flocculating agent Substances 0.000 description 1
- 230000003311 flocculating effect Effects 0.000 description 1
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- 238000004817 gas chromatography Methods 0.000 description 1
- 125000001475 halogen functional group Chemical group 0.000 description 1
- 230000004217 heart function Effects 0.000 description 1
- 229910000037 hydrogen sulfide Inorganic materials 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 150000001261 hydroxy acids Chemical class 0.000 description 1
- 230000015784 hyperosmotic salinity response Effects 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- PZOUSPYUWWUPPK-UHFFFAOYSA-N indole Natural products CC1=CC=CC2=C1C=CN2 PZOUSPYUWWUPPK-UHFFFAOYSA-N 0.000 description 1
- RKJUIXBNRJVNHR-UHFFFAOYSA-N indolenine Natural products C1=CC=C2CC=NC2=C1 RKJUIXBNRJVNHR-UHFFFAOYSA-N 0.000 description 1
- 238000009655 industrial fermentation Methods 0.000 description 1
- 238000009776 industrial production Methods 0.000 description 1
- 239000008235 industrial water Substances 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 150000002497 iodine compounds Chemical class 0.000 description 1
- 159000000014 iron salts Chemical class 0.000 description 1
- MVFCKEFYUDZOCX-UHFFFAOYSA-N iron(2+);dinitrate Chemical compound [Fe+2].[O-][N+]([O-])=O.[O-][N+]([O-])=O MVFCKEFYUDZOCX-UHFFFAOYSA-N 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- 159000000003 magnesium salts Chemical class 0.000 description 1
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 1
- 235000019341 magnesium sulphate Nutrition 0.000 description 1
- 229940045184 malt extract Drugs 0.000 description 1
- 150000002696 manganese Chemical class 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- QZIQJVCYUQZDIR-UHFFFAOYSA-N mechlorethamine hydrochloride Chemical compound Cl.ClCCN(C)CCCl QZIQJVCYUQZDIR-UHFFFAOYSA-N 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 150000002751 molybdenum Chemical class 0.000 description 1
- 235000021281 monounsaturated fatty acids Nutrition 0.000 description 1
- 239000012452 mother liquor Substances 0.000 description 1
- 239000010413 mother solution Substances 0.000 description 1
- 230000004899 motility Effects 0.000 description 1
- 206010028417 myasthenia gravis Diseases 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 229910017464 nitrogen compound Inorganic materials 0.000 description 1
- 150000002830 nitrogen compounds Chemical class 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 125000001477 organic nitrogen group Chemical group 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 239000008177 pharmaceutical agent Substances 0.000 description 1
- 235000021317 phosphate Nutrition 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 235000011118 potassium hydroxide Nutrition 0.000 description 1
- 159000000001 potassium salts Chemical class 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 229940079877 pyrogallol Drugs 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 159000000000 sodium salts Chemical class 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000003068 static effect Effects 0.000 description 1
- 239000008223 sterile water Substances 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 239000001384 succinic acid Substances 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- FKHIFSZMMVMEQY-UHFFFAOYSA-N talc Chemical compound [Mg+2].[O-][Si]([O-])=O FKHIFSZMMVMEQY-UHFFFAOYSA-N 0.000 description 1
- 238000012546 transfer Methods 0.000 description 1
- QNTNKSLOFHEFPK-UPTCCGCDSA-N ubiquinol-10 Chemical compound COC1=C(O)C(C)=C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)C(O)=C1OC QNTNKSLOFHEFPK-UPTCCGCDSA-N 0.000 description 1
- SOECUQMRSRVZQQ-UHFFFAOYSA-N ubiquinone-1 Chemical compound COC1=C(OC)C(=O)C(CC=C(C)C)=C(C)C1=O SOECUQMRSRVZQQ-UHFFFAOYSA-N 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 150000003751 zinc Chemical class 0.000 description 1
Abstract
Description
【発明の詳細な説明】
〔産業上の利用分野〕
本発明は、補酵素Q +oの製造法に関し、さらに詳細
には、微生物を使用した補酵素Q10の製造法に係わる
。DETAILED DESCRIPTION OF THE INVENTION [Industrial Application Field] The present invention relates to a method for producing coenzyme Q +o, and more particularly to a method for producing coenzyme Q10 using microorganisms.
補酵素QIGは、生体内の末端呼吸系の電子伝達体とし
て重要な役割を果たし、心臓機能先進剤、重症筋無力症
治療剤、肺気腫治療剤、再生不良性貧血治療剤および円
形脱毛症治療剤などの医薬品ならびに飼料添加剤などと
して有用な化合物として知られている。Coenzyme QIG plays an important role as an electron carrier in the terminal respiratory system in vivo, and is used as an agent for advanced cardiac function, a treatment for myasthenia gravis, a treatment for pulmonary emphysema, a treatment for aplastic anemia, and a treatment for alopecia areata. It is known as a compound that is useful as a pharmaceutical agent and feed additive.
〔従来の技術、発明が解決しようとする問題点〕従来、
補酵素Q10は、動物および植物などのそれぞれの組織
から抽出され、さらに、精製することにより製造されて
おり、品質の均一性に問題があり、また、原料の供給が
不安定であった。[Prior art, problems to be solved by the invention] Conventionally,
Coenzyme Q10 is extracted from tissues of animals and plants, and is produced by further purification, which has problems with uniformity of quality and unstable supply of raw materials.
このような欠点を回避するための一方法として、最近で
は、微生物を培養して得られた菌体から補酵素Q10を
抽出する方法が知られている。As one method for avoiding such drawbacks, a method has recently been known in which coenzyme Q10 is extracted from cells obtained by culturing microorganisms.
しかしながら、微生物の補酵素Q10の生産性は、実用
に供するには、まだ、充分ではなく、補酵素Q10の生
産性の大きい微生物の発見が期待されている。However, the productivity of coenzyme Q10 in microorganisms is still not sufficient for practical use, and the discovery of microorganisms with high productivity of coenzyme Q10 is expected.
本発明は、微生物を使用し、効率よく補酵素Q l。The present invention uses microorganisms to efficiently produce coenzyme Q1.
を製造する方法を提供することを目的とする。The purpose is to provide a method for manufacturing.
本発明者らは、補酵素Q10を多量に生産する菌株を見
出すべく研究を重ねた結果、オリゴモナス属に属する菌
株が、その菌体内に多量の補酵素Q + 。The present inventors conducted repeated research to find a strain that produces a large amount of coenzyme Q10, and as a result, a strain belonging to the genus Oligomonas produced a large amount of coenzyme Q + within its bacterial body.
を多量に生産、蓄積することを見出し、本発明に到達し
た。The present invention was achieved by discovering that it is possible to produce and accumulate large quantities of.
すなわち、本発明は、オリゴモナス属に属する補酵素Q
10生産細菌を培養して菌体を得、得られた菌体から補
酵素QIoを分離、回収することを特徴とする補酵素Q
1oの製造法である。That is, the present invention provides coenzyme Q belonging to the genus Oligomonas.
10 Coenzyme Q characterized by culturing producing bacteria to obtain bacterial cells, and separating and recovering coenzyme QIo from the obtained bacterial cells.
This is the manufacturing method of 1o.
本発明に用いられる細菌は、アルカリ性で生育、増殖し
、メタノールを唯一の炭素源として資化することができ
、グラム陰性で、かつ、補酵素Q10を生産する細菌で
ある。本細菌は、その菌学的性質によれば、従来知られ
ている属、種には該当するものはみられず、本細菌は、
新しい属に属する細菌と判断した。The bacteria used in the present invention grow and multiply in alkaline conditions, can assimilate methanol as a sole carbon source, are Gram-negative, and produce coenzyme Q10. According to its mycological properties, this bacterium does not belong to any previously known genus or species;
It was determined that the bacteria belonged to a new genus.
本発明者らは、本細菌について、新居を設立する必要が
あると考えてオリゴモナスO1igomonas属と命
名した。The present inventors thought that this bacterium needed to establish a new home and named it the genus Oligomonas.
本発明のアルカリ性メタノール資化性細菌のうち、代表
的な菌株である0−3(微工研菌寄第9280号)。Among the alkaline methanol-assimilating bacteria of the present invention, a representative strain 0-3 (Feikoken Bacteria Collection No. 9280).
0−75(微工研菌寄第9281号)および0−100
(微工研菌寄第9282号)のそれぞれの菌学的性質を
示す。0-75 (Feikoken Bibori No. 9281) and 0-100
(Feikoken Bibori No. 9282) and their mycological properties are shown.
菌学的性質:
(1)顕微鏡的形態
NazCO3で、pH9,0に調整した肉汁液体培地お
よび肉汁寒天培地で30°Cで3日間培養した。Mycological properties: (1) Microscopic form NazCO3 was cultured at 30°C for 3 days in broth liquid medium and broth agar medium adjusted to pH 9.0.
■ 細胞の形状および大きさ
通常は、球菌または短桿菌、幅0.5〜Q、34゜長さ
0.5〜1.5−
■ 運動性 なし。■ Cell shape and size Usually cocci or short bacilli, width 0.5-Q, 34° length 0.5-1.5- ■ Motility None.
■ 胞子の有無 生産されない。■ Presence or absence of spores Not produced.
■ グラム染色 グラム陰性
■ 抗酸性 陰性
(2)各種の培地における生育状態
■ Na2CO3でpH9,0に調整した肉汁平板培養
30°Cで3日間培養。■ Gram stain Gram negative ■ Acid-fast negative (2) Growth status in various media ■ Juicy plate culture adjusted to pH 9.0 with Na2CO3 Cultured at 30°C for 3 days.
中程度の生育を示す。Shows medium growth.
コロニーの形状:外形は円形、大きさは2〜3nm、隆
起は半球状、構造は均質、表面は平滑、辺縁は平滑で金
縁、色は黄白色で光沢あり、透明度は不透明、硬度はバ
ター質。Colony shape: external shape is circular, size is 2-3 nm, ridges are hemispherical, structure is homogeneous, surface is smooth, edges are smooth and gold-rimmed, color is yellowish white and glossy, transparency is opaque, hardness is butter quality.
■ メタノール含有寒天平板培養 30’Cで3日間培養。■Methanol-containing agar plate culture Culture at 30'C for 3 days.
■と同じ。Same as ■.
■ Na2CO3でpl+ 9.0に調整した肉汁寒天
斜面培養
30″Cで3日間培養。■ Broth agar slant culture adjusted to pl+ 9.0 with Na2CO3. Cultured at 30"C for 3 days.
接種線に一様に旺盛に生育する。Grows vigorously and uniformly along the inoculation line.
隆起は中程度、表面は平滑、辺縁は平滑で金縁、色は黄
白色で光沢あり、透明度は不透明、硬度はパター質。The ridges are moderate, the surface is smooth, the edges are smooth and gold-rimmed, the color is yellowish-white and shiny, the transparency is opaque, and the hardness is putty.
■ メタノール含有寒天斜面培養 30°Cで3日間培養。■ Methanol-containing agar slant culture Culture at 30°C for 3 days.
■と同じ。Same as ■.
■ NazCO:+でpH9,0に調整した肉汁培養3
0°Cで3日間培養。■ Meat juice culture 3 adjusted to pH 9.0 with NazCO:+
Culture at 0°C for 3 days.
全体に生育する。沈澱あり。Grows all over. There is precipitation.
■ NazCO=でpH9,0に調整したペプトン水3
0°Cで5日間培養。■ Peptone water 3 adjusted to pH 9.0 with NazCO=
Culture at 0°C for 5 days.
全体に生育する。しかし、生育は旺盛ではない。Grows all over. However, growth is not vigorous.
■ メタノール含有液体培地 30゛Cで3日間培養。■ Methanol-containing liquid medium Culture at 30°C for 3 days.
全体に生育する。沈澱あり。Grows all over. There is precipitation.
■ NazCOlでpu 9.0に調整した肉汁寒天穿
刺培養
30’Cで3日間培養。■ Broth agar puncture culture adjusted to pu 9.0 with NazCOl. Cultured at 30'C for 3 days.
小乳頭状に一様に生育する。培地表面では、直径2〜4
閤ぐらいの円状に生育する。Grows uniformly in the form of small papillae. On the surface of the medium, the diameter is 2-4
It grows in a circular shape about the size of a bell.
■ メタノール含有穿刺培養 30°Cで3日間培養。■ Puncture culture containing methanol Culture at 30°C for 3 days.
小乳頭状に一様に生育する。培地表面では、直径2〜4
[lll1ぐらいの円状に生育する。Grows uniformly in the form of small papillae. On the surface of the medium, the diameter is 2-4
[Grows in a circular shape about 1ll1.
[相] Na2CO3でpH9,0に調整した肉汁ゼラ
チン高層培養
20°Cで10日間培養。[Phase] Broth gelatin multilayer culture adjusted to pH 9.0 with Na2CO3. Cultured at 20°C for 10 days.
菌の生育はみられるが、ゼラチンは液化されない。Although bacterial growth is observed, the gelatin is not liquefied.
■ NazCO=でpH9,0に調整したリドマスミル
ク30°Cで4週間培養。■ Cultured for 4 weeks at 30°C in lidmus milk adjusted to pH 9.0 with NazCO=.
菌の生育はみられるが、リドマスミルクの凝固はおこら
ない。Although bacterial growth is observed, lidmus milk does not coagulate.
(3)生理学的性質 ■ 硝酸塩の還元 硝酸塩を亜硝酸塩に還元する。(3) Physiological properties ■ Nitrate reduction Reduces nitrate to nitrite.
ただし、0−3株の還元能は弱い。However, the reducing ability of the 0-3 strain is weak.
■ vr’テスト 陰性
■ インドールの生成 陰性
■ 硫化水素の生成 陰性
■ でん粉の加水分解 陰性
■ くえん酸の利用(クリステンセンChristen
sen培地) 陰性
■ 窒素源の利用
アンモニウム塩、硝酸塩、尿素およびペプトンを窒素源
として利用する。■ VR' test negative ■ Formation of indole negative ■ Formation of hydrogen sulfide negative ■ Starch hydrolysis negative ■ Utilization of citric acid (Christen)
sen medium) Negative ■ Use of nitrogen sources Ammonium salts, nitrates, urea and peptone are used as nitrogen sources.
■ 色素の生成 生成しない。■ Pigment production: No pigment production.
■ ウレアーゼ 陽性 [相] カタラーゼ 陽性 ■ アンモニアの生成 生成する。■ Urease positive [Phase] Catalase Positive ■Generation of ammonia Generate.
@ 脱窒反応 陰性
■ オキシダーゼ 陽性
Q O−Fテスト 陰性
■ 生育の範囲
pH7〜10の範囲で生育する。pl+ 7.5〜9.
5が好ましい。p118〜9が特に好ましい。@ Denitrification reaction negative ■ Oxidase positive Q O-F test negative ■ Growth range Grows in the pH range of 7 to 10. pl+ 7.5-9.
5 is preferred. Particularly preferred are p118-9.
5°C937°Cでは生育しない。It does not grow at 5°C937°C.
@) IJi類の資化性 + (W) :弱く生育する ■ tJl! #N以外の炭素源の資化性■ 耐塩性 3重量%NaC1含有培地で弱く生育する。@) Assimilation of IJi species + (W): Grows weakly ■ tJl! # Assimilation of carbon sources other than N■ Salt tolerance It grows weakly in a medium containing 3% by weight NaCl.
■ ビタミン要求性 ビオチンを要求する。■ Vitamin requirement Requires biotin.
@CC(グアニン士シトシン)含量
0−3 63.9molχ0−75
64.7molχ0−100
64.4mol″′t■ 主要な菌体脂肪酸組成
モノ不飽和脂肪酸 CIl+□
@ 主要なヒドロキシ酸
3−ヒドロキシ酸C108゜
3−ヒドロキシ酸C14,。@CC (guanine cytosine) content 0-3 63.9molχ0-75
64.7molχ0-100
64.4 mol'''t■ Main bacterial cell fatty acid composition Monounsaturated fatty acid CIl+□ @ Main hydroxy acid 3-hydroxy acid C108゜3-hydroxy acid C14.
0 キノンタイプ
ユビキノンQ−10
[相] 分離源
土壌
バージイズ マニュアル オブ システマティック バ
クテリオロジー(Bergey’s Manual o
fSystematic Bacteriology
)第1巻(編集者 クリーブ(Krieg)およびホル
ト(IlolL)) :ウィリアムズ アンド ゥィ
ルキンス社(Williams & Wilkins)
。0 Quinone type Ubiquinone Q-10 [Phase] Separation source soil Bergey's Manual of Systematic Bacteriology
fSystematic Bacteriology
) Volume 1 (editors Krieg and Holt): Williams & Wilkins
.
(1984) )によると、これらの菌株は、ダラム陰
性、球菌または短桿菌および好気性であることから、’
5ection 4 のGram−Negativ
e Aerobic Rods andCocc
i Jに含まれるものと考えられる。この5ectio
nには、37の属が記載されている。本細菌をこれらの
属と比較すると、球菌または短桿菌であり、運動性がな
く、GC含量の点から、Paracoccus属に近い
といえる。しかしながら、本細菌は、脱窒能がない点か
らParacoccus属についての記載と一致しない
。また、r’aracoccus属に属する菌種として
は、P、denitrificans とP、halo
denitrificansとが存在するが、これらの
菌種とは脱窒能および生育pl+の点で異なる。(1984), these strains are Durham-negative, cocci or short bacilli, and aerobic;
Gram-Negative of 5ection 4
e Aerobic Rods and Cocc
It is considered to be included in iJ. This 5ectio
37 genera are described in n. Comparing this bacterium with these genera, it can be said that it is a coccus or a short bacillus, is non-motile, and is close to the genus Paracoccus in terms of GC content. However, this bacterium does not match the description regarding the genus Paracoccus in that it does not have denitrifying ability. In addition, bacterial species belonging to the genus r'aracoccus include P. denitrificans and P. halo.
denitrificans, but they differ from these species in terms of denitrification ability and growth pl+.
従って、本発明者らは、本細菌を新居に属させることと
して、オリゴモナス(01igomonas)属と命名
し、また、菌種としてオリゴモナス メタノリカ(Ol
igomonas methanolica)と命名し
た。Therefore, the present inventors assigned this bacterium to a new family and named it the genus Oligomonas, and also named the bacterium Oligomonas methanolica (Oligomonas).
Igomonas methanolica).
本発明において、菌学的性質を調べるための実験方法は
、前記のハージイズ マニュアル、医科学研究所学友会
編[細菌学実習提要J (1958)および長谷用
底冷 編著「微生物の分類と同定」(1975)に準拠
した。In the present invention, the experimental method for investigating mycological properties is described in the above-mentioned Harsey's Manual, edited by the Institute of Medical Science Alumni Association [Bacteriology Practice Summary J (1958) and Hase's
Based on "Classification and Identification of Microorganisms" (1975), edited by Sokoi.
また、メタノール含有寒天平板培地、メタノール含有寒
天斜面培地として次の組成の培地を用いた(実施例でも
同様)。すなわち、(NHs)zsOa 3g、に1l
zPO41,4g 、NaJPOs 2.1 g 5M
g50448200.2 g 、CaC1z・211z
030mg、FeCJsO7・XIIzo 30+ng
。Furthermore, a medium having the following composition was used as a methanol-containing agar plate medium and a methanol-containing agar slant medium (the same applies to Examples). That is, (NHs)zsOa 3g, 1l
zPO41.4g, NaJPOs 2.1g 5M
g50448200.2 g, CaC1z・211z
030mg, FeCJsO7・XIIzo 30+ng
.
MnCIz’411205mg+ ZnS044Hz0
5mg、Cu5Oa・5t1200.5mgおよびディ
フコ(Dirco)社製寒天(バクトアガ−Bacto
−agar) 15 gを純水11に溶解し、1 kg
/ crA Gで20分間殺菌したのち10重量%N
a2CO。MnCIz'411205mg+ ZnS044Hz0
5mg, Cu5Oa・5t1200.5mg and Dirco agar (Bacto agar)
-agar) 15 g in pure water 11, 1 kg
/ After sterilizing with crA G for 20 minutes, 10% N by weight
a2CO.
水溶液を無菌的に加え、pHを9.0に調整した。また
、さらにメタノール8−を無菌的に添加して、平板培地
または斜面培地を作成した。また、メタノール含有液体
培地としては、前記の培地において寒天を添加しないも
のを用いた。The aqueous solution was added aseptically and the pH was adjusted to 9.0. Furthermore, methanol 8- was added aseptically to prepare a plate culture medium or a slant culture medium. Furthermore, as the methanol-containing liquid medium, the above-mentioned medium to which agar was not added was used.
土壌からの本細菌の分離は、前記のメタノール含有培地
を用い常法で行った。Isolation of this bacterium from soil was carried out in a conventional manner using the methanol-containing medium described above.
本細菌の培養に使用する培地は、本細菌が資化し得る炭
素源を含有していることを要し、さらに適量の窒素源お
よび無機物などを含有する培地ならば合成培地および天
然培地のどちらでもよい。The medium used for culturing this bacterium must contain a carbon source that can be assimilated by this bacterium, and may be either a synthetic medium or a natural medium as long as it contains an appropriate amount of nitrogen source and inorganic substances. good.
炭素源としては、本細菌が資化し得る炭素源であれば特
に制限はないが、メタノールのほかにエタノールなどの
合成炭素源を好適に使用し得るが、その他の炭素源−た
とえば、糖蜜、ペプトンおよび肉エキスなどの天然物、
アラビノース、キシロース、グルコース、マンノース、
フラクトースおよびガラクトースなと゛の*唐頚、ソル
ビトールンニトールおよびイノシトールなと′のネ唐ア
ルコール、また、こはく酸などの有機酸なども使用する
ことができる。これらのうち、工業用の醗酵原料として
は、メタノールが最も好ましい。培地におけるこれらの
炭素源の濃度は、炭素源の種類により適宜選択される。There are no particular restrictions on the carbon source as long as it is a carbon source that can be assimilated by this bacterium. In addition to methanol, synthetic carbon sources such as ethanol can be suitably used, but other carbon sources such as molasses and peptone can also be used. and natural products such as meat extracts,
arabinose, xylose, glucose, mannose,
Alcohols such as fructose and galactose, sorbitol, nitol and inositol, and organic acids such as succinic acid can also be used. Among these, methanol is the most preferred as an industrial fermentation raw material. The concentration of these carbon sources in the medium is appropriately selected depending on the type of carbon source.
たとえば、炭素源がメタノールの場合には、培地または
培養液のメタノール濃度は6重量%以下が好ましく、菌
の生育および増殖の良好さからは3重量%以下が特に好
ましい。For example, when the carbon source is methanol, the methanol concentration in the medium or culture solution is preferably 6% by weight or less, and particularly preferably 3% by weight or less from the viewpoint of good bacterial growth and proliferation.
窒素源としては、たとえば、アンモニウム塩、硝酸塩な
どの無機窒素化合物および/または、たとえば、尿素、
コーン・ステイブ・リカー、カゼイン、ペプトン、酵母
エキス、肉エキスなどの有機窒素含有物が用いられる。Nitrogen sources include, for example, inorganic nitrogen compounds such as ammonium salts, nitrates and/or e.g. urea,
Organic nitrogen-containing substances such as corn stave liquor, casein, peptone, yeast extract, and meat extract are used.
また、無機成分としては、たとえば、カルシウム塩、マ
グネシウム塩、カリウム塩、ナトリウム塩、りん酸塩、
マンガン塩、亜鉛塩、鉄塩、銅塩、モリブデン塩、コバ
ルト塩、はう素化合物およびよう素化合物が用いられる
。In addition, examples of inorganic components include calcium salts, magnesium salts, potassium salts, sodium salts, phosphates,
Manganese salts, zinc salts, iron salts, copper salts, molybdenum salts, cobalt salts, boron compounds and iodine compounds are used.
さらに、アミノ酸、核酸、ビタミン、酵母エキスおよび
麦芽エキスなどの生育促進物質も使用される。In addition, growth promoting substances such as amino acids, nucleic acids, vitamins, yeast extract and malt extract are also used.
また、使用される細菌が、栄養要求性を示す場合には、
その要求物質を存在させる必要がある。In addition, if the bacteria used are auxotrophic,
It is necessary to make the required substance exist.
培養条件は、温度20〜42°C1好ましくは25〜4
0”C,pf17〜10,好ましくは7.5〜9.5で
ある。このような条件で好気的に培養を行う。これらの
条件をはずれて培養した場合には、本細菌の増殖は比較
的悪くなるが、これらの条件をはずして培養することを
妨げない。The culture conditions include a temperature of 20-42°C, preferably 25-42°C.
0"C, pf 17 to 10, preferably 7.5 to 9.5. Cultivation is carried out aerobically under these conditions. If culture is performed outside these conditions, the growth of this bacterium will not occur. Although it will be relatively worse, it does not prevent culturing outside these conditions.
また、培養液の溶存酸素濃度には特に制限はないが、通
常は、0.5〜20ppmが好ましい。そのために、通
気量を調節したり、撹拌したり、通気ガスとして酸素も
しくは酸素と空気との混合ガスを使用したり、また、培
養槽内の圧力を高めるなどの手段が採用される。また、
培養方式は、回分培養または連続培養のいずれでもよい
。Further, there is no particular restriction on the dissolved oxygen concentration of the culture solution, but it is usually preferably 0.5 to 20 ppm. For this purpose, measures such as adjusting the amount of aeration, stirring, using oxygen or a mixed gas of oxygen and air as the aeration gas, and increasing the pressure inside the culture tank are adopted. Also,
The culture method may be either batch culture or continuous culture.
窒素源としてアンモニウム塩を使用した場合には、培養
期間中にアンモニアが菌体生産のために消費されて培養
液のpHが低下する。この場合に、培養液のpHを所定
の値に保つために、アンモニア、苛性カリおよび苛性ソ
ーダなどのアルカリを添加するが、アンモニアを添加す
ることが好ましい。When ammonium salt is used as a nitrogen source, ammonia is consumed for bacterial cell production during the culture period, and the pH of the culture solution decreases. In this case, in order to maintain the pH of the culture solution at a predetermined value, an alkali such as ammonia, caustic potash, and caustic soda is added, and it is preferable to add ammonia.
このようにして、細菌を培養したのち、菌体を培養液か
ら分離する。分離には通常の固液分離手段が採用される
。すなわち、固液分離手段としては、たとえば、培養液
そのものをそのまま遠心分離するとの手段、培養液中に
本細菌よりも大きい他の微生物を濾過助剤として加えた
り、または、プレコートすることにより培養液から菌体
を濾過分離するとの手段、培養液に種々の凝集剤を加え
て菌体を凝集させて、この凝集菌体を濾過もしくは遠心
分離により培養液から分離するとの手段、培養液のpH
を5以下にすることにより、または、pHを5以下にし
さらに50〜too’cで加熱することにより菌体を凝
集させて、この凝集菌体を濾過もしくは遠心分離により
培養液から分離するとの手段などを適用し得る。After culturing the bacteria in this manner, the bacterial bodies are separated from the culture solution. For separation, ordinary solid-liquid separation means are employed. In other words, solid-liquid separation means include, for example, centrifuging the culture solution itself, adding other microorganisms larger than the present bacteria to the culture solution as a filter aid, or pre-coating the culture solution. Means for separating bacterial cells by filtration, means for flocculating bacterial cells by adding various flocculants to the culture solution, and separating the flocculated cells from the culture solution by filtration or centrifugation, and the pH of the culture solution.
5 or less, or by adjusting the pH to 5 or less and heating at 50 to 50°C to aggregate the bacterial cells, and then separating the aggregated bacterial cells from the culture solution by filtration or centrifugation. etc. can be applied.
分離されたままの菌体、または、たとえば、噴霧乾燥な
どによる乾燥菌体から補酵素Q10を抽出し、この補酵
素Q10は必要に応じてさらに精製に付される。Coenzyme Q10 is extracted from isolated bacterial cells or dried bacterial cells, for example, by spray drying, and this coenzyme Q10 is further purified if necessary.
補酵素Q10の分離、抽出および精製は、補酵素Q10
に適用されている通常の分離抽出法および精製法によっ
て行なうことができる。すなわち、たとえば、エタノー
ル、メタノールもしくはアセトンに菌体を懸濁させて、
50〜90°Cで1時間加熱して抽出して抽出液を得る
。または、まず、メタノール、水酸化ナトリウムおよび
ピロガロールの混合物を用いて、菌体中のりん脂質など
のけん化性物質をけん化してけん化法を得る。これらの
抽出液もしくはけん化法から、たとえば、n−ヘキサン
のような有機溶媒によって補酵素Q10を抽出して抽出
物を得る。ついで、この抽出物から、たとえば、ハイポ
ーラスポリマーのような多孔性合成樹脂、シリカゲルお
よびフロリジルなどを用いて、補酵素QIOを分別、単
離し、精製する。Separation, extraction and purification of coenzyme Q10
This can be carried out by conventional separation/extraction methods and purification methods that are applied to. That is, for example, by suspending bacterial cells in ethanol, methanol, or acetone,
Extract by heating at 50-90°C for 1 hour to obtain an extract. Alternatively, a saponification method is obtained by first saponifying saponifiable substances such as phospholipids in the bacterial cells using a mixture of methanol, sodium hydroxide, and pyrogallol. Coenzyme Q10 is extracted from these extracts or saponification using an organic solvent such as n-hexane to obtain an extract. Then, coenzyme QIO is fractionated, isolated, and purified from this extract using, for example, a porous synthetic resin such as a high-porous polymer, silica gel, and Florisil.
菌体から得られた補酵素Q loの同定、定量には、一
般に、高速液体クロマトグラフィー、元素分析。High performance liquid chromatography and elemental analysis are generally used to identify and quantify coenzyme Q lo obtained from bacterial cells.
融点測定、赤外部吸収スペクトル、紫外部吸収スペクト
ル、核磁気共鳴スペクトルおよび質量分析などの手段が
それぞれ用いられる。Means such as melting point measurement, infrared absorption spectroscopy, ultraviolet absorption spectroscopy, nuclear magnetic resonance spectroscopy, and mass spectrometry are used.
実施例によって本発明をさらに具体的に説明する。なお
、本発明は、実施例に限定されるものではない。The present invention will be explained in more detail with reference to Examples. Note that the present invention is not limited to the examples.
実施例1
オリゴ」ナス メタノリカの菌」」
土壌サンプル約0.5〜1gを殺菌水10−に無菌的に
入れ、この懸濁液l−をメタノール含有寒天平板培地上
に液深がほぼ一様になるように入れ、水分をこの寒天培
地に吸収させたのち、28“Cで約7日間静置培養を行
なった。この寒天培地上に生成したコロニーの一部分を
さらにメタノール含有寒天平板培地で培養して得られた
単一コロニーを、メタノール含有寒天斜面培地に植菌し
て培養して、オリゴモナス メタノリカ0−3、同0−
75および同0−100 のそれぞれを得た。Example 1 Approximately 0.5 to 1 g of a soil sample of ``Oligo ``Eggplant methanolica fungus'' was aseptically placed in sterile water 10-, and this suspension 1- was placed on a methanol-containing agar plate medium so that the liquid depth was almost uniform. After allowing water to be absorbed into the agar medium, static culture was performed at 28"C for about 7 days. A portion of the colony that had formed on this agar medium was further cultured on an agar plate medium containing methanol. The single colony obtained was inoculated onto a methanol-containing agar slant medium and cultured to obtain Oligomonas methanolica 0-3, Oligomonas methanolica 0-
75 and 0-100, respectively.
補酵素Q10の製造
純水11あたり、(NH4) zsO,3g 、に1(
zPOn 1.8 g 。Production of coenzyme Q10 per 11 of pure water, (NH4) zsO, 3g, 1 (
zPOn 1.8 g.
NazHPO42,1g、 MgSO4’7HzO0,
2g、 CaC1g・2Hz0301g、FeCJsO
t’XHz0 30mg+ MnCIz・4H205m
g。NazHPO42,1g, MgSO4'7HzO0,
2g, CaC1g・2Hz0301g, FeCJsO
t'XHz0 30mg+ MnCIz・4H205m
g.
ZnSO4・7Hz0 5 mg、 CuSO4°5L
OQ、5mg、 NazCO32,5g、ビオチン2眉
およびメタノール8m1lを溶解し、pit 9.0に
調整した培地(以下 培地A と記す)30II1.を
100−容三角フラスコに分注し、120°Cで20分
間殺菌した。 寒天20g/lを添加したメタノール含
有寒天培地(Na2CO3を含まない培地を120°C
で20分間殺菌し、これに別に殺菌した10重量%Na
、CO3水溶液を培地10 dあたり0.25耐添加し
て作成した)で30″C,3日間培養したオリゴモナス
メタノリカ0−100 (微工研菌寄第9282号)
の1白金耳を100耐容三角フラスコ中の培地Aに接種
し、30°Cでロータリー・シェーカーで回転数220
回/分の回転振盪培養を行なった。 この培養液を種
母液とした。ZnSO4・7Hz0 5 mg, CuSO4°5L
A medium containing 5 mg of OQ, 2.5 g of NazCO, 2 ml of biotin and 8 ml of methanol (hereinafter referred to as medium A) 30II1. was dispensed into a 100-capacity Erlenmeyer flask and sterilized at 120°C for 20 minutes. Methanol-containing agar medium supplemented with 20 g/l of agar (na2CO3-free medium at 120°C)
sterilized for 20 minutes, then separately sterilized 10 wt% Na
Oligomonas methanolica 0-100 (made by adding 0.25 CO3 aqueous solution per 10 d of culture medium) at 30''C for 3 days (Feikoken Bacterial Serial No. 9282)
Inoculate medium A in a 100-capacity Erlenmeyer flask and shake at 30°C with a rotary shaker at 220 rpm.
Rotary shaking culture was performed once per minute. This culture solution was used as a seed mother solution.
工業用水11あf、:、す、(NH4) zsOa
1 g 1Mg5O,a。Industrial water 11af,:,su, (NH4) zsOa
1 g 1Mg5O, a.
7tlz0 1.5 g 、 KII2PO44,5g
、 FeCJsOy・XHz030mg、 CaC]
z’2Hz0 90mg、 ZnSO4’411z0
15mg。7tlz0 1.5 g, KII2PO44.5g
, FeCJsOy・XHz030mg, CaC]
z'2Hz0 90mg, ZnSO4'411z0
15mg.
MnCl2°411z0 15111g 、 CLIS
O4°51hO1,5mg。MnCl2°411z0 15111g, CLIS
O4°51hO1.5mg.
(Nlla)aMO7(h4’4Hzo 1.0mg
、 CoCIz・211z0 1.0ffllLFI3
PO4t、omg、 NaCl 50mg、 Kl
1.0mgおよびビオチン80IIgを含む培地(培
地B)liを30ffi容培養槽に入れ、殺菌後、アン
モニア水でpi−19,0に調整し、メタノール40m
1および種母液200mjをそれぞれ添加した。細菌が
増殖するに従って、培養液中のメタノール濃度が低下し
たが、このメタノール濃度をガスクロマトグラフィーで
分析し、培養液中のメタノール濃度が0.1〜062重
量%になるようにメタノールを補給した。培養温度30
°C1培養液のpH9,0,撹拌機の回転数(撹拌羽根
の半径71mm) 800回/分および通気量1vvm
で通気(空気を使用)撹拌培養を行なったところ、世代
時間が約4時間で細菌が増殖した。培養を開始してから
、48時間後に、培養液を遠心分離し、得られた菌体を
凍結乾燥して乾燥菌体90gを得た。(Nlla)aMO7(h4'4Hzo 1.0mg
, CoCIz・211z0 1.0ffllLFI3
PO4t, omg, NaCl 50mg, Kl
A medium (medium B) containing 1.0 mg of biotin and 80 II g of biotin was placed in a 30 ffi culture tank, and after sterilization, the pi was adjusted to pi-19.0 with aqueous ammonia, and 40 m of methanol was added.
1 and 200 mj of seed mother liquor were added respectively. As the bacteria proliferated, the methanol concentration in the culture solution decreased, but this methanol concentration was analyzed by gas chromatography, and methanol was replenished so that the methanol concentration in the culture solution was 0.1 to 0.62% by weight. . Culture temperature 30
°C1 culture solution pH 9.0, stirrer rotation speed (stirring blade radius 71 mm) 800 times/min and aeration rate 1vvm
When aeration (using air) agitation culture was carried out, bacteria proliferated in about 4 hours. After 48 hours from the start of the culture, the culture solution was centrifuged, and the resulting bacterial cells were freeze-dried to obtain 90 g of dried bacterial cells.
この乾燥菌体から補酵素Q Ioを、インプロパツール
濃度が90容量χのイソプロパツール水溶液で抽出し、
ついで、ヘキサン転溶を行ない、得られたヘキサン溶液
中の還元型補酵素Q10を硝酸鉄で酸化した後、このヘ
キサン溶液について、高速液体クロマトグラフィーで補
酵素Q10を同定し、その含量を測定した。その結果か
ら、乾燥菌体1gあたり1.60■の補酵素Q10が得
られたことになる。Coenzyme Q Io was extracted from the dried bacterial cells with an aqueous solution of isopropanol with an inpropanol concentration of 90 volumes χ,
Next, hexane transfer was performed, and after oxidizing the reduced coenzyme Q10 in the obtained hexane solution with iron nitrate, coenzyme Q10 was identified in this hexane solution by high performance liquid chromatography, and its content was measured. . The results show that 1.60 μ of coenzyme Q10 was obtained per 1 g of dry bacterial cells.
本発明によれば、工業生産により安定して容易に入手し
得る物質をも原料として使用することができ、さらに、
細菌を使用して、補酵素Q10を容易に、効率よ(、し
かも、安定して製造することが可能となる。According to the present invention, substances that are stable and easily available through industrial production can also be used as raw materials, and further,
Coenzyme Q10 can be easily, efficiently (and stably produced) using bacteria.
また、特に、本発明における細菌は、好アルカリ性細菌
なので培養における雑菌による汚染が著しく低減される
。Moreover, in particular, since the bacteria in the present invention are alkaliphilic bacteria, contamination by undesirable bacteria during culture is significantly reduced.
特許出願人 三菱瓦斯化学株式会社 代表者長野 和書Patent applicant: Mitsubishi Gas Chemical Co., Ltd. Representative Nagano Japanese book
Claims (1)
養して菌体を得、得られた菌体から補酵素Q_1_0を
分離、回収することを特徴とする補酵素Q_1_0の製
造法A method for producing coenzyme Q_1_0, which comprises culturing coenzyme Q_1_0-producing bacteria belonging to the genus Oligomonas to obtain bacterial cells, and separating and recovering coenzyme Q_1_0 from the obtained bacterial cells.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62151059A JPS63317092A (en) | 1987-06-19 | 1987-06-19 | Production of coenzyme q10 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP62151059A JPS63317092A (en) | 1987-06-19 | 1987-06-19 | Production of coenzyme q10 |
Publications (1)
Publication Number | Publication Date |
---|---|
JPS63317092A true JPS63317092A (en) | 1988-12-26 |
Family
ID=15510399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP62151059A Pending JPS63317092A (en) | 1987-06-19 | 1987-06-19 | Production of coenzyme q10 |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS63317092A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP1553185A4 (en) * | 2002-07-25 | 2007-08-08 | Kyowa Hakko Kogyo Kk | Process for producing solution containing ubiquinone-10 |
JP2008253271A (en) * | 2001-12-27 | 2008-10-23 | Kaneka Corp | Method for producing coenzyme q10 |
WO2019208676A1 (en) * | 2018-04-27 | 2019-10-31 | 株式会社カネカ | Method for producing coenzyme q10 |
-
1987
- 1987-06-19 JP JP62151059A patent/JPS63317092A/en active Pending
Cited By (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2008253271A (en) * | 2001-12-27 | 2008-10-23 | Kaneka Corp | Method for producing coenzyme q10 |
JP2012157360A (en) * | 2001-12-27 | 2012-08-23 | Kaneka Corp | Processes for producing coenzyme q10 |
US9315839B2 (en) | 2001-12-27 | 2016-04-19 | Kaneka Corporation | Processes for producing coenzyme Q10 |
US9926580B2 (en) | 2001-12-27 | 2018-03-27 | Kaneka Corporation | Process for producing coenzyme Q10 |
EP1553185A4 (en) * | 2002-07-25 | 2007-08-08 | Kyowa Hakko Kogyo Kk | Process for producing solution containing ubiquinone-10 |
WO2019208676A1 (en) * | 2018-04-27 | 2019-10-31 | 株式会社カネカ | Method for producing coenzyme q10 |
JPWO2019208676A1 (en) * | 2018-04-27 | 2021-05-13 | 株式会社カネカ | Method for producing coenzyme Q10 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Foster | Microbiological aspects of riboflavin: I. Introduction. II. Bacterial oxidation of riboflavin to lumichrome | |
KR910002857B1 (en) | Process for the biotechnological preparation of poly -d- (-) -3- hydroxybutyric acid | |
FR2461753A1 (en) | PROCESS FOR THE PREPARATION OF A CEPHALOSPORINE BY FERMENTATION AND MICROORGANISM FOR CARRYING OUT SAID METHOD | |
JPS63317092A (en) | Production of coenzyme q10 | |
SU421199A3 (en) | METHOD OF OBTAINING BIOMASS | |
US4104124A (en) | Process for the production of single cell protein and amino acids | |
JP3525190B2 (en) | Strain producing ε-poly-L-lysine in remarkable quantity and method for producing ε-poly-L-lysine using the same | |
HU176399B (en) | Processs for producing cell-mateiral of bacteria | |
JP2518218B2 (en) | Method for producing microbial cell | |
JPH012592A (en) | Production method of pyrroloquinoline quinone | |
US4278766A (en) | Mutant microorganisms useful for the production of single cell protein and amino acids | |
JPS6291177A (en) | Production of selenium-containing microbial cell | |
JPS63248383A (en) | Novel microorganism | |
JPS6251999A (en) | Production of hyaluronic acid | |
JPS589672B2 (en) | Biseibutsunobayouhouhou | |
JP2800005B2 (en) | Method for producing deoxyribonucleic acid | |
JPS5939296A (en) | Preparation of l-tryptophan using bacterium | |
KR810000509B1 (en) | Process for the preparation of single cell protein | |
JPS5858071B2 (en) | Method for producing bacterial cells | |
JPS5817589B2 (en) | Koubonoseizouhou | |
JPS6034195A (en) | Preparation of 5-hydroxy-l-tryptophan | |
JP2019180283A (en) | Method for producing urolithin | |
JPS619293A (en) | Production of l-amino acid | |
JPH02207795A (en) | Novel bacterium and production of 2-thiopheneacetic acid using the same bacterium | |
JPH06113869A (en) | Production of s@(3754/24)+)-citramalic acid |